Evidence map›Paper›PMID 40768526›Full record

ArticlePLOS global public health2025

High prevalence of multidrug-resistant and ESBL-producing bacteria in a primary healthcare facility in Accra, Ghana: A cross-sectional study.

Frank Twum Aboagye, Mawutor Kwame Ahiabu, Hannah Segbefiah Akahoho, Emmanuel Armah, Samuel G Anang, Naa A S Amarteifio, Christabel Amoo, Abena Konadu Owusu-Senyah Enninful, Queenstar Dedei Quarshie, Naa Adjeley Kuma and 2 more

Abstract read
In one paragraph

Article in PLOS global public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Frank Twum AboagyeBiomedical and Public Health Research Unit, Water Research Institute, Council for Scientific and Industrial Research, Accra, Ghana.ORCID https://orcid.org/0000-0002-3881-9789
Mawutor Kwame AhiabuThe Graduate School, Augusta University, Augusta, Georgia, United States of America.ORCID https://orcid.org/0000-0002-9608-3554
Hannah Segbefiah AkahohoDepartment of Genetics and Biochemistry, Clemson University, Clemson, South Carolina, United States of America.ORCID https://orcid.org/0009-0002-2741-8899
Emmanuel ArmahBiomedical and Public Health Research Unit, Water Research Institute, Council for Scientific and Industrial Research, Accra, Ghana.ORCID https://orcid.org/0000-0001-9364-9690
Samuel G AnangDepartment of Medical Laboratory Technology, Faculty of Applied Sciences, Accra Technical University, Accra, Ghana.
Naa A S AmarteifioDepartment of Medical Laboratory Technology, Faculty of Applied Sciences, Accra Technical University, Accra, Ghana.
Christabel AmooDepartment of Medical Laboratory Technology, Faculty of Applied Sciences, Accra Technical University, Accra, Ghana.
Abena Konadu Owusu-Senyah EnninfulBiomedical and Public Health Research Unit, Water Research Institute, Council for Scientific and Industrial Research, Accra, Ghana.ORCID https://orcid.org/0000-0003-4513-2958
Queenstar Dedei QuarshieBiomedical and Public Health Research Unit, Water Research Institute, Council for Scientific and Industrial Research, Accra, Ghana.ORCID https://orcid.org/0000-0003-4890-9101
Naa Adjeley KumaBiomedical and Public Health Research Unit, Water Research Institute, Council for Scientific and Industrial Research, Accra, Ghana.ORCID https://orcid.org/0009-0008-8132-0212
Judith WayoBiomedical and Public Health Research Unit, Water Research Institute, Council for Scientific and Industrial Research, Accra, Ghana.
Kantanka Addo-OsafoDepartment of Medical Microbiology, University of Ghana Medical School, University of Ghana, Korle Bu, Accra, Ghana.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial resistance (AMR) is a global public health crisis, particularly in low- and middle-income countries where empirical antibiotic use is common. Data on bacterial resistance patterns in primary healthcare settings remain limited in Ghana, impeding effective treatment guidelines and infection control measures. This cross-sectional study, conducted at Shalina Health Centre in Accra, Ghana, between May and November 2024, examined bacterial infections among 156 systematically sampled patients. Clinical specimens underwent bacterial culture, identification via Gram staining and biochemical tests, and antibiotic susceptibility testing using the Kirby-Bauer disc diffusion method. Extended-spectrum beta-lactamase (ESBL) production was assessed per Clinical and Laboratory Standards Institute (CLSI) guidelines. Statistical analysis included prevalence estimation with 95% confidence intervals and subgroup comparisons using ANOVA and Chi-square tests. Bacterial infections were detected in 62.20% [97/156] of participants, with Escherichia coli [43.30%], Staphylococcus aureus [21.65%], and Klebsiella pneumoniae [19.59%] as the most prevalent pathogens. Gram-negative bacteria accounted for 75.26% of isolates. Females exhibited a significantly higher infection rate [69.64%] than males [43.18%] [p = 0.002]. Multidrug resistance (MDR) was widespread [97.94%], and 76.06% of Enterobacteriaceae isolates were ESBL producers. Resistance to fluoroquinolones, cephalosporins, and beta-lactams was particularly high among Gram-negative isolates. The study highlights the high burden of multidrug-resistant bacteria in primary healthcare settings, with significant resistance to key antibiotics. These findings emphasize the urgent need for enhanced antimicrobial stewardship, evidence-based prescribing practices, and strengthened infection prevention measures. Surveillance in non-tertiary healthcare facilities is crucial to mitigate AMR transmission and optimize treatment protocols in Ghana and similar settings.

Identifiers

PMID40768526
PMCPMC12327667

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.